Sentences with phrase «with a biotech company for»

In the past, when we've talked to various pharmaceutical companies about one program or another in our lab, they often want to wait until it's been developed into a preliminary screen, and would rather work with biotech companies for collaborations — they've often been the intermediate window before a pharmaceutical company would step in.

Otherwise, I'm interviewing with a biotech company for a great sales position and I'm going through the process with Abbott, Merck and AstraZeneca.

Not exact matches

One biotech firm, Ossianix, is already hard at work developing a VNAR - based drug - delivery system, in collaboration with the global pharmaceutical company Lundbeck, which focuses on drugs for brain disorders.

And within a span of six weeks this fall, Hillary Clinton caused a drop in biotech stocks with a tweet calling for greater regulation of drug prices, then single - handedly tanked stocks of private - corrections companies when she tweeted about prison reform.

The genetics company received a payment of $ 10 million (with «as much as $ 50 million» in additional payments down the line) from the biotech firm in exchange for access to its library of genetic data, Forbes reports.

Yesterday, the company announced that it is teaming up with the biotech firm Genetech to try and identify new treatments for Parkinson's disease.

CNBC's Meg Tirrell speaks with Verily Chief Medical Officer Dr. Jessica Mega about the role Alphabet plays in the biotech company and what it could mean for the future of medicine.

The premiums that pharma companies pay for biotechs with mid-to-late stage experimental drugs has risen to a point that has some analysts crying «bubble.»

DuPont Pioneer has been collaborating on research and intellectual property with Caribou Biosciences, the biotech company cofounded by Jennifer Doudna, one of the discoverers of CRISPR, for sometime now.

Minoryx is a clinical stage biotech company leading the development of new therapies for X-linked Adrenoleukodystrophy (X-ALD) and other inborn errors of metabolism, a group of rare diseases of genetic origin with a high unmet medical need.

People looking for a bubble in the broader tech sector tend to watch biotech moves because those companies --- often venture - backed and often beckoning with potentially explosive results — are considered barometers of how much appetite investors have for risk.

DASNY also hired the consulting firm Deloitte to research potential sites for the new lab for a now completed report that also includes the identification of universities and companies that might want to partner with Wadsworth on health research innovation and a biotech accelerator program.

The IBM hub is one of the three major Buffalo Billion projects, along with the $ 750 million solar panel factory for Tesla in South Buffalo and $ 50 million for lab space on the medical campus for biotech company Albany Molecular Research Inc..

Sen. Kirsten Gillibrand is in the North Country, touring Myriad RBM, a biotech company, in Saranac Lake at 9 a.m., joining Rep. Bill Owens for a roundtable on cross-border commerce at 11 a.m. (SUNY Plattsburgh), and announcing an effort to spur science and tech job growth with Clarkson President Tony Collins at 1:30 p.m.

Cuomo called the state's $ 200 million deal with the biotech company Athenex «a game - changer for Dunkirk.»

With collaboration between the Department of Health, SUNY Poly's nanobioscience department and biotech companies, officials envisioned it serving as «a model for public health innovation to other states and nations.»

The latest round of START - UP participants was announced Monday in Buffalo, with companies that range from software developers for the legal profession and a biotech firm working on genetic markers for autism to a developer of brain injury drugs.

He has helped found at least two dozen biotech companies, with foci ranging from cancer drug delivery to products for hair and skin.

Arman's first job after graduation was with a technical and business - development consultancy for early - stage biotech companies called CMA Consultants in Los Angeles, California.

Robl and Stice, in collaboration with the biotech company Genzyme of Cambridge, Massachusetts, have already created embryos that contain the human gene for albumin protein, which helps restore the blood's osmotic pressure after blood loss.

For the new study, Dr. Schwarcz and his team collaborated closely with scientists at the Karolinska Institute in Stockholm, Sweden, the University of Leicester in the United Kingdom, and KynuRex, a biotech company in San Francisco.

Although the bulk of the commercial manufacturing uses cultures of bacteria, such as Escherichia coli or Chinese hamster ovary cells, a few biotech companies are trying to produce therapeutic proteins in the milk of transgenic mammals (such as GTC Biotherapeutics, which is using goats; PPL Therapeutics, which is using sheep; and BioProtein Technologies, which is working with rabbits), transgenic chicken eggs (such as Avigenics or Vivalis), or even in transgenic crops (such as ProdiGene or Meristem Therapeutics); but it is early days for these «pharming» methods.

Take, for example, a biotech company based in Cambridge, Massachusetts, with the apt name of Elixir Pharmaceuticals.

In order to separate the 200 - some compounds in breast milk so they could be analyzed individually, Lebrilla worked with a biotech company to develop a microchip that acts like a filter for the machine, allowing different compounds through at different speeds.

The uncertain outcome hasn't scared the pharmaceutical and biotech companies she works with away from their plans for CRISPR, she said.

Thus for me the decision to pursue a career in the business of biotech investing was easy, especially since at a time of stock market hype, venture capital companies were looking for people with biotech knowledge and business experience.

Susan Schade, a UAB alumna who now does research for a small biotech company in Birmingham, says that the IR helped her in its «exposure to different career paths and networking» and allowed her «to make contact with all kinds of people not at UAB.»

With the proper clearance, bench scientists at the NIH should have the right «to do what every other scientist has the right to do: consult for a science advisory committee or a pharmaceutical company or a biotech company, partly because that's become part of the culture and partly because it's very much a two - way exchange,» Alberts says.

In addition to stipends, the companies pay for those postdocs to attend conferences, and arrange educational sessions with people in the business side of biotech so that they — the postdocs — can learn entrepreneurial skills, Shamp says.

University of Tübingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria ® PfSPZ - CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.

«An entire generation of biotech projects was being shelved,» says Alan Eisenberg, executive vice president for Emerging Companies and Business Development at the Biotechnology Industry Organization in Washington, D.C. BIO pushed for the program along with patient - advocacy groups.

For Pancer, the award enabled his return to academic research in the United States after holding a position with a biotech company in Israel.

The need for biologists with additional qualifications in business administration (whether via MBA or distance learning or other courses) will increase as biotech companies, banks, and consultants look for people who understand both — the technology and the business.

The research scientist just 4 years into her first industry job with a company that makes diagnostic tests and reagents, who finds as she reenters the job market that she is not a strong candidate for bench - science jobs in the biotech industry because she has been labeled a «diagnostics industry» employee.

In Germany, for example, the Munich - based biotech company apceth has already treated patients» gastrointestinal cancer with stem cells harvested from their own bone marrow and modified to convert a prodrug called ganciclovir.

The White House announced last July that it would revise the nearly 24 - year - old framework for how companies should clear agricultural biotech products, such as genetically modified (GM) crops and animals, with the Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), and the Environmental Protection Agency (EPA).

Many of the skills and techniques employed in drug discovery are quite marketable to pharmaceutical and biotech companies and, with the new NIH directive, perhaps even for academic positions.

But because they're a small biotech company, with high risk of default (i.e., a high risk of not paying off their debts), they would have to pay a very high interest rate in order to make the bond attractive enough for investors to purchase it.

Now, a small biotech start - up is providing an alternative for those critics who want to mine Iceland's genetic riches but do not want to cooperate with the company that has exclusive rights to the database.

It paid $ 30 million for access to the RNA interference know - how and patents held by the biotech company Alnylam, and it did a similar deal with Tekmira, an RNA delivery specialist based in Burnaby, British Columbia.

From that chat has arisen plans for the MSD Wellcome Trust Hilleman Laboratories — named after a vaccine scientist who worked at Merck — a non-profit research institute that it will act like a nimble biotech company with «dynamic decision - making» in the words of Ted Bianco, director of technology transfer at the Wellcome Trust.

About the Anna - Maria Kellen Clinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innovation.

With more than 1,200 international actors from 35 + countries, such as big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia - industry collaborations and early - stage innovations in the field of Life Sciences.

The company is looking for investors - but unless you are a sophisticated investor with experience in biotech investments, we wouldn't recommend it.

«With extensive experience at both large and small agriculture and industrial biotech companies, she is uniquely positioned to help Caribou capitalize on the potential opportunities for CRISPR - Cas gene editing to develop improved crops and bio-based products.»

Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life - threatening medical conditions and more than 100 projects in the pipeline.

For example, scaling up manufacturing, regulatory issues, and partnerships with biotech companies.

Consequently, the safest investment in the ESC field may be «something where you're an enabler of the technology» by providing the raw tools and ingredients for ESC research, says Steve Brozak, an analyst with WBB Securities in San Diego, Calif. «The time frame [for ESCs] is now for drug discovery, soon for personalized medicine, and decades for therapeutic use,» adds Bob Palay, chairman and CEO of Cellular Dynamics International (CDI), a biotech company working with ESCs in Madison, Wisc..

Just three years since a Japanese researcher first reprogrammed ordinary skin cells into stem cells without the use of embryos, scientists at a Massachusetts biotech company have repeated the feat, only this time with a new method that creates the first stem cells safe enough for -LSB-...]

In 2001 Scheller began a new career with the biotech company Genentech as Senior Vice President for Research, where he enjoyed the freedom to continue basic research and publishing new findings in cell biology, including proteins called Rab GTPases, which regulate the transport of structures within cells.